Back to Search
Start Over
The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapya combined analysis of two randomised, placebo-controlled phase III clinical trials
The oral NK1 antagonist, aprepitant, given with standard antiemetics provides protection against nausea and vomiting over multiple cycles of cisplatin-based chemotherapya combined analysis of two randomised, placebo-controlled phase III clinical trials
- Source :
- European Journal of Cancer. 40:403-410
- Publication Year :
- 2004
- Publisher :
- Elsevier BV, 2004.
- Subjects :
- Cancer Research
Oncology
Subjects
Details
- ISSN :
- 09598049
- Volume :
- 40
- Database :
- OpenAIRE
- Journal :
- European Journal of Cancer
- Accession number :
- edsair.doi...........62145730b508834036535746ac93501f
- Full Text :
- https://doi.org/10.1016/s0959-8049(03)00931-6